Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
IBS04 - Hyperprogressive Disease (Ticketed Session)
- 07:00 - 08:00
- 9/08/2019
- Location: Amsterdam (2011)
- IASLC CME Accredited
- Type: Interactive Breakfast Session
- Track: Immuno-oncology
-
+
IBS04.01 - Biological Mechanisms
07:00 - 07:20 | Presenter: Edward Garon
- Abstract
Loading...
-
+
OA04 - Immuno Combinations and the Role of TMB
- 15:15 - 16:45
- 9/08/2019
- Location: Copenhagen (1980)
- IASLC CME Accredited
- Type: Oral Session
- Track: Immuno-oncology
- Moderators:Solange Peters, Martin Reck
-
+
OA04.06 - Evaluation of TMB in KEYNOTE-189: Pembrolizumab Plus Chemotherapy vs Placebo Plus Chemotherapy for Nonsquamous NSCLC
16:10 - 16:20 | Presenter: Marina Chiara Garassino | Author(s): Delvys Rodriguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Giovanna Speranza, Martin Reck, Rina Hui, Michael Boyer, Razvan Cristescu, Deepti Aurora-Garg, Andrew Albright, Andrey Loboda, Julie Kobie, Jared K. Lunceford, Mark Ayers, Gregory M Lubiniecki, Bilal Piperdi, M. Catherine Pietanza, Edward Garon
- Abstract
Loading...
-
+
EP1.04 - Immuno-oncology
- 08:00 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
EP1.04-20 - Phase I Trial of in Situ Vaccination with Autologous CCL21-Modified Dendritic Cells (CCL21-DC) Combined with Pembrolizumab for Advanced NSCLC
08:00 - 08:00 | Presenter: Aaron Lisberg | Author(s): Bin Liu, Ramin Salehi-Rad, Jay Moon Lee, Linh Tran, Kostyantyn Krysan, Rui Li, Ying Lin, Alan Tseng, Fereidoun Abtin, Robert Suh, Scott Oh, Denise Aberle, Lauren Winter, W. Dean Wallace, David Elashoff, Edward Garon, Sherven Sharma, Steven Dubinett
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-107 - KEYNOTE-495/KeyImPaCT: Phase 2 Biomarker-Directed Study of Pembrolizumab-Based Therapy for Non–Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Martin Gutierrez | Author(s): Matthew Hellmann, Matthew A. Gubens, Charu Aggarwal, Daniel SW Tan, Enriqueta Felip, Wei-Sen Lam, Joanne Wing Yan Chiu, Jong-Seok Lee, James Chih-Hsin Yang, Edward Garon, Andrea Basso, Hua Ma, Lawrence Fong, Alex Snyder, Jianda Yuan, Roy S. Herbst
- Abstract
Loading... -
+
P1.01-133 - Randomized Open-Label Study of Bintrafusp Alfa (M7824) vs Pembrolizumab in Patients with PD-L1 Expressing Advanced 1L NSCLC
09:45 - 09:45 | Presenter: Myung-Ju Ahn | Author(s): Fabrice Barlesi, Enriqueta Felip, Edward Garon, Claudio Martin, Tony Mok, Everett E. Vokes, Laureen S. Ojalvo, Andre Koenig, Isabelle Dussault, Luis Paz-Ares
- Abstract
Loading... -
+
P1.01-73 - An Explorative Analysis of Pemetrexed +/- Pembrolizumab Maintenance from KEYNOTE-189 Versus PARAMOUNT, PRONOUNCE, and JVBL
09:45 - 09:45 | Presenter: Edward Garon | Author(s): Ramaswamy Govindan, Vassiliki A Papadimitrakopoulou, Chunxiao Wang, Rocio Varea, Jong Seok Kim, Joachim G.J.V. Aerts
- Abstract
Loading...
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-33 - Deep Phenotyping of Immune Populations Reveals Baseline Predictors of Pembrolizumab Efficacy in NSCLC on KEYNOTE-001
09:45 - 09:45 | Presenter: Philippe Rochigneux | Author(s): Aaron Lisberg, Alejandro Garcia, Anne Sophie Chretien, Stephane Fattori, Anne Madroszyk, Alan Tseng, Wisdom Akingbemi, Jaklin Gukasyan, John Madrigal, James Carroll, Zorawar Noor, Amy Lauren Cummings, Daniel Olive, Edward Garon
- Abstract
Loading...
-
+
P1.12 - Small Cell Lung Cancer/NET
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Small Cell Lung Cancer/NET
-
+
P1.12-22 - A Phase 1b/2 Study of Niraparib Plus Temozolomide Versus Standard Care as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer Patients
09:45 - 09:45 | Presenter: Amy Lauren Cummings | Author(s): Edward Garon, Zev A Wainberg, Jonathan Goldman
- Abstract
Loading...
-
+
P1.18 - Treatment of Locoregional Disease - NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment of Locoregional Disease - NSCLC
-
+
P1.18-01 - RELAY EU/US Subset: Ramucirumab Plus Erlotinib Improves Progression-Free Survival in First-Line EGFR Mutation-Positive NSCLC
09:45 - 09:45 | Presenter: Santiago Ponce Aix | Author(s): Silvia Novello, Edward Garon, Kazuhiko Nakagawa, Ernest Nadal, Denis Moro-Sibilot, Miriam Alonso Garcia, Elizabeth Fabre, Bente Frimodt-Moller, Annamaria Hayden Zimmermann, Carla M Visseren-Grul, Martin Reck
- Abstract
Loading...
-
+
MA11 - Immunotherapy in Special Populations and Predictive Markers
- 14:00 - 15:30
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Immuno-oncology
- Moderators:Frank Griesinger, Lecia Sequist
-
+
MA11.11 - STK11/LKB1 Genomic Alterations Are Associated with Inferior Clinical Outcomes with Chemo-Immunotherapy in Non-Squamous NSCLC
15:10 - 15:15 | Presenter: John Victor Heymach | Author(s): Ferdinandos Skoulidis, Kathryn C. Arbour, Matthew Hellmann, Pradnya Dinkar Patil, Melina E Marmarelis, Dwight Hall Owen, Mark Awad, Joseph C. Murray, Benjamin Philip Levy, Jessica Hellyer, Justin F. Gainor, Tyler Stewart, Sarah B. Goldberg, Anastasios Dimou, Christine M Bestvina, Amy Lauren Cummings, Yasir Elamin, Vincent Lam, Jianjun Zhang, Catherine Shu, Jonathan Wesley Riess, Collin M Blakely, Chad V. Pecot, Laura Mezquita, Fabrizio Tabbò, Adrian G Sacher, Matthias Scheffler, Biagio Ricciuti, Deepti Venkatraman, Hira Rizvi, Corinne Liu, Rocio Perez Johnston, Ying Ni, Joseph Azok, Melanie Wain Kier, Sharyn I Katz, Kurtis D. Davies, Jeremy P Segal, Lauren Ritterhouse, Hiram Shaish, LUDOVIC Lacroix, Regan Memmott, John R Madrigal, Jonathan Goldman, Sally CM Lau, Jonathan Killam, Zenta Walther, Brett Carter, Mark Woodcock, Jack Roth, Stephen Swisher, Natasha B Leighl, Subba Digumarthy, Meghan Mooradian, Julia Rotow, Juergen Wolf, Giorgio Vittorio Scagliotti, David Planchard, Benjamin Besse, Trever G Bivona, David R Gandara, Edward Garon, Naiyer A Rizvi, D. Ross Camidge, Kurt A Schalper, Roy S. Herbst, Alice T. Shaw, Joel W Neal, Heather A Wakelee, Julie R Brahmer, Pasi A Jänne, David P Carbone, Charu Aggarwal, Nathan Pennell, Charles M Rudin, Vassiliki A Papadimitrakopoulou
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P2.01-02 - CANOPY-A: A Phase 3 Study of Canakinumab as Adjuvant Therapy in Patients with Surgically Resected NSCLC
10:15 - 10:15 | Presenter: Edward Garon | Author(s): Andrea Ardizzoni, Fabrice Barlesi, Byoung Chul Cho, Pedro De Marchi, Yasushi Goto, Shun Lu, Luis Paz-Ares, David R Spigel, Michael Thomas, Bijoyesh Mookerjee, Pilar Cazorla Arratia, Jason Baum, Zhu Zewen, James Chih-Hsin Yang
- Abstract
Loading...
-
+
P2.04 - Immuno-oncology
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P2.04-88 - Surgical Outcomes of a Multicenter Phase II Trial of Neoadjuvant Atezolizumab in Resectable Stages IB-IIIB NSCLC: Update on LCMC3 Clinical Trial
10:15 - 10:15 | Presenter: Jay M Lee | Author(s): Jamie E. Chaft, Alan Nicholas, G Alec Patterson, Saiama Waqar, ERIC M Toloza, Eric B Haura, DAN J Raz, Karen L Reckamp, ROBERT E Merritt, Dwight Hall Owen, DAVID J Finley, CIARAN J McNamee, Justin D Blasberg, Edward Garon, JOHN D Mitchell, Robert C. Doebele, FRANK A Baciewicz, Misako Nagasaka, Harvey I Pass, Ann Johnson, See-Chun Phan, Katja Schulze, Paul A Bunn, Jr, Bruce E Johnson, Mark G Kris, David J Kwiatkowski, Ignacio Wistuba, David P Carbone, Valerie W. Rusch
- Abstract
Loading...
